ArticleCancers2023

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.

Lien Provez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.